The University of Tokyo · Medicine
Professor Katsuhito Fujiu's research lab focuses on the role of transcription factors, particularly KLF5, in regulating inflammation and tissue remodeling in chronic diseases. The lab investigates how KLF5 influences immune cell activation and dysfunction in organs such as the kidney, heart, and blood vessels, especially in the context of fibrosis, chronic injury, and systemic comorbidities. A central theme is the interplay between hematopoietic stem cells, macrophage polarization, and organ crosstalk in conditions like heart failure and chronic kidney disease. The lab also explores therapeutic strategies targeting KLF5 and retinoid signaling to prevent vascular and fibrotic pathologies.
Figures are computed from collected data and may differ slightly.
Renal tubulointerstitial damage is the final common pathway leading from chronic kidney disease to end-stage renal disease. Inflammation is clearly involved in tubulointerstitial injury, but it remains unclear how the inflammatory processes are initiated and regulated. Here, we have shown that in the mouse kidney, the transcription factor Krüppel-like factor-5 (KLF5) is mainly expressed in collecting duct epithelial cells and that Klf5 haploinsufficient mice (Klf5+/- mice) exhibit ameliorated re
The heart is composed of several cell types including cardiomyocytes, cardiac fibroblasts, endothelial, and smooth muscle cells. In addition to these major cell types, cardiac macrophages are also present in small numbers under physiological conditions. Recently, the resident macrophage is considered to have vital functions in the maintenance of tissues and homeostasis in many organs, including brain, liver, adipose tissue, lymphatic tissue, and intestinal tract. However, detailed functions of t
Modulation of smooth muscle cell (SMC) phenotype plays a central role in neointima formation. We recently demonstrated that Am80, a synthetic retinoic acid receptor alpha-specific agonist, inhibits the activity of the transcription factor KLF5, which is essential for neointima formation after vascular injury. In the present study, we aimed to further analyze the mechanism by which Am80 inhibits KLF5 and the effects of inhibiting KLF5 on SMCs and vascular lesion formation, as well as to evaluate
Patients with heart failure (HF) often experience repeated acute decompensation and develop comorbidities such as chronic kidney disease and frailty syndrome. Although this suggests pathological interaction among comorbidities, the mechanisms linking them are poorly understood. Here, we identified alterations in hematopoietic stem cells (HSCs) as a critical driver of recurrent HF and associated comorbidities. Bone marrow transplantation from HF-experienced mice resulted in spontaneous cardiac dy
Open papers in the app to read, cite, and organize with AI.
